Hereditary Genetic Testing
Uncover genetic risks and take preventive steps
to protect your health.
What is the HALO PathWay™?
Hereditary genetic testing helps identify genetic risks for certain health conditions, enabling early prevention, detection, and personalized medical care.
The HALO hereditary gene panel tests for genes commonly associated with cancers that run in families, such as breast, prostate, ovarian, endometrial, pancreatic, gastric, and colorectal cancers. It empowers patients to make well-informed decisions about their health and identifies what screening tests are available for earlier cancer detection, when illness is most treatable.
Detect early, act early: Uncover genetic risks and take preventive steps to protect your health.
How long does it take to get test results?
A simple saliva sample will be collected and sent to our molecular laboratory for analysis. Your results will be delivered directly to your provider in about 3 weeks.
Why is hereditary genetic testing important?
If you or any of your family members have ever been diagnosed with cancer, genetic testing can help identify inherited genetic abnormalities that may increase your chances of developing certain types of disease. By understanding the underlying cause behind a history of cancer, doctors and medical professionals can better determine preventive measures and effective treatments for you and your family.
The HALO PathWay™ hereditary genetic test can empower informed decision making, to help you better understand your lifetime risks for certain syndromes.
Is there a cost associated with testing?
Most insurance carriers cover genetic testing services for hereditary cancer. Although each case is unique, the average patient pays nothing out of pocket. HALO Precision Diagnostics assists in obtaining the best possible reimbursement for genetic testing with the goal of making sure you receive the appropriate coverage from your insurance plan.
We are committed to making testing affordable to all patients. Any Questions?
For more information about
HALO Precision Diagnostics.
This refers to relatives such as parents, siblings, grandparents, your children, aunts, uncles, and first-cousins.
- Breast cancer under 50
- Ovarian cancer at any age
- Male breast cancer at any age
- Two breast cancers in one relative at any age
- Three or more breast cancers in relatives on the same side of the family at any age
- Metastatic prostate or pancreatic cancer in a first degree relative
- Ashkenazi Jewish ancestry with a relative with breast cancer at any age
- Colon, rectal or uterine cancer at 49 or younger
- A gene mutation found in a family member
- Breast cancer at any age
- Ovarian cancer at any age
- Metastatic prostate cancer at any age
- Pancreatic cancer at any age
- Endometrial or Colorectal cancer under 65
Your genetic data is kept safe and secure
The Genetic Information Non-discrimination Act (GINA) and laws in most states prohibit discrimination regarding employment eligibility, health benefits, or health insurance premiums solely based on genetic information.
ABOUT HALO PRECISION DIAGNOSTICS
HALO Diagnostics is the leader in early disease detection using precision diagnostics. The company’s outpatient Precision Diagnostic Centers are reshaping the healthcare ecosystem by integrating advanced imaging, digital pathology, molecular genomics, and predictive analytics under one roof, in a lower-cost, outpatient setting. HALO makes early-stage disease screening and diagnosis faster and more convenient for patients and physicians alike. With a HALO PathWay™ for breast, prostate, neuro, and cardiac disease, HALO is increasing early disease detection and saving lives. HALO currently serves one million patients, a number expected to triple by 2024.